Edition:
India

Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

19.74USD
13 Jul 2018
Change (% chg)

$-0.24 (-1.20%)
Prev Close
$19.98
Open
$19.89
Day's High
$20.32
Day's Low
$19.40
Volume
242,672
Avg. Vol
171,434
52-wk High
$29.80
52-wk Low
$9.03

Chart for

About

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides... (more)

Overall

Beta: --
Market Cap(Mil.): $348.59
Shares Outstanding(Mil.): 29.57
Dividend: --
Yield (%): --

Financials

  COLL.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -3.65 -- --
ROI: -99.46 15.07 14.61
ROE: -101.15 16.60 16.34

BRIEF-Collegium Reports Q1 Loss Per Share $0.57

* COLLEGIUM REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

10 May 2018

BRIEF-Collegium Appoints Shirley Kuhlmann As General Counsel

* COLLEGIUM ANNOUNCES THE APPOINTMENT OF SHIRLEY KUHLMANN AS GENERAL COUNSEL Source text for Eikon: Further company coverage:

19 Mar 2018

BRIEF-Collegium Reports Q4 Loss Per Share $0.54

* COLLEGIUM REPORTS FOURTH QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08 Mar 2018

BRIEF-Collegium To Host Conference Call To Discuss Fourth Quarter 2017 Financial Results And Provide Corporate Update

* COLLEGIUM TO HOST CONFERENCE CALL TO DISCUSS FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE Source text for Eikon: Further company coverage:

27 Feb 2018

BRIEF-Collegium Filed Patent Infringement Lawsuit Against Teva Pharma USA

* COLLEGIUM PHARMA SAYS FILED PATENT INFRINGEMENT LAWSUIT IN U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE AGAINST TEVA PHARMACEUTICALS USA INC

23 Feb 2018

Earnings vs. Estimates